Staff training makes a difference: improvements in neonatal illicit drug testing and intervention at a tertiary hospital

References

• Results from the 2011 National Survey on Drug Use and Health: summary of National Findings. Available from http://www.samhsa.gov/data/NSDUH/2k11Results/NSDUHresults2011.pdf [last accessed 12 Dec 2012]
   Google Scholar
• Ostrea EM, Brady M, Gause S, et al. Drug screening of newborns by meconium analysis: a large-scale, prospective, epidemiologic study. Pediatrics 1992;89:107–13
   PubMed Web of Science ®Google Scholar
• Bauer CR, Shankaran S, Bada HS, et al. The maternal lifestyle study: drug exposure during pregnancy and short-term maternal outcomes. Am J Obstet Gynecol 2002;186:487–95
   PubMed Web of Science ®Google Scholar
• Bar-Oz B, Klein J, Karaskov T, Koren G. Comparison of meconium and neonatal hair analysis for detection of gestational exposure to drugs of abuse. Arch Dis Child Fetal Neonatal Ed 2003;88:98–100
   PubMed Web of Science ®Google Scholar
• Bauer CR, Langer JC, Shankaran S, et al. Acute neonatal effects of cocaine exposure during pregnancy. Arch Pediatr Adolesc Med 2005;159:824–34
   PubMedGoogle Scholar
• Lester BM, ElSohly M, Wright LL, et al. The Maternal Lifestyle Study: drug use by meconium toxicology and maternal self-report. Pediatrics 2001;107:309–17
   PubMed Web of Science ®Google Scholar
• Schutzman DL, Frankenfield-Chernicoff M, Clatterbaugh HE, Singer J. Incidence of intrauterine cocaine exposure in a suburban setting. Pediatrics 1991;88:825–27
   PubMed Web of Science ®Google Scholar
• Adirim TA, Sen Gupta N. A national survey of state maternal and newborn drug testing and reporting policies. Public Health Rep 1991;106:292–6
   PubMed Web of Science ®Google Scholar
• Iowa Child Abuse Figures Drop in 2008. Available from http://www.docstoc.com/docs/53918405/IOWA-CHILD-ABUSE-FIGURES-DROP-IN-2008 [last accessed 12 Dec 2012]
   Google Scholar
• Oral R, Bayman L, Assad A, et al. Illicit drug exposure in patients evaluated for alleged child abuse and neglect. Pediatr Emerg Care 2011;27:490–5
   PubMed Web of Science ®Google Scholar
• Brown JV, Bakeman R, Coles CD, et al. Prenatal cocaine exposure: a comparison of 2-year-old children in parental and nonparental care. Child Dev 2004;75:1282–95
   PubMed Web of Science ®Google Scholar
• Bada HS, Das A, Bauer CR, et al. Gestational cocaine exposure and intrauterine growth: maternal lifestyle study. Obstet Gynecol 2002;100:916–24
   PubMed Web of Science ®Google Scholar
• Bada HS, Das A, Bauer CR, et al. Low birth weight and preterm births: etiologic fraction attributable to prenatal drug exposure. J Perinatol 2005;25:631–7
   PubMedGoogle Scholar
• Bada HS, Langer J, Twomey J, et al. Importance of stability of early living arrangements on behavior outcomes of children with and without prenatal drug exposure. J Dev Behav Pediatr 2008;29:173–82
   PubMed Web of Science ®Google Scholar
• Neonatal drug withdrawal. American Academy of Pediatrics Committee on Drugs. Pediatrics 1998;101:1079–88
   Google Scholar
• Drug-exposed infants. American Academy of Pediatrics Committee on Substance Abuse. Pediatrics 1995;96:364–7
   Google Scholar
• Patrick SW, Schumacher RE, Benneyworth BD, et al. Neonatal abstinence syndrome and associated health care expenditures: United States, 2000–2009. J Am Med Assoc 2012;307:1934–40
   PubMed Web of Science ®Google Scholar
• Jaudes PK, Ekwo E, Van Voorhis J. Association of drug abuse and child abuse. Child Abuse Negl 1995;19:1065–75
   PubMed Web of Science ®Google Scholar
• Jaudes PK, Ekwo EE. Outcomes for infants exposed in utero to illicit drugs. Child Welfare 1997;76:521–34
   PubMed Web of Science ®Google Scholar
• Hans SL. Demographic and psychosocial characteristics of substance-abusing pregnant women. Clin Perinatol 1999;26:55–74
   PubMed Web of Science ®Google Scholar
• Ostrea EM, Knapp DK, Tannenbaum L, et al. Estimates of illicit drug use during pregnancy by maternal interview, hair analysis, and meconium analysis. J Pediatr 2001;138:344–8
   PubMed Web of Science ®Google Scholar
• Montgomery D, Plate C, Alder SC, et al. Testing for fetal exposure to illicit drugs using umbilical cord tissue vs. meconium. J Perinatol 2006;26:11–14
   PubMed Web of Science ®Google Scholar
• Oral R, Strang T. Neonatal illicit drug screening practices in Iowa: the impact of utilization of a structured screening protocol. J Perinatol 2006;26:660–6
   PubMedGoogle Scholar
• Oral R, Koc F, Bayman EO, et al. Perinatal illicit drug screening practices in mother-newborn dyads at a university hospital serving rural/semi-urban communities: translation of research to quality improvement. J Matern Fetal Neonatal Med 2012;25:2441–6
   PubMed Web of Science ®Google Scholar
• Wallman CM, Smith PB, Moore K. Implementing a perinatal substance abuse screening tool. Adv Neonatal Care 2011;11:255–67
   PubMedGoogle Scholar
• Brennan C, Newton M, Wood F, et al. Training general practitioners in remote Western Australia in a method of screening and brief intervention for harmful alcohol use: a pilot study. Aust J Rural Health 2013;21:72–9
   PubMedGoogle Scholar
• Keough VA, Jennrich JA. Including a screening and brief alcohol intervention program in the care of the obstetric patient. J Obstet Gynecol Neonatal Nurs 2009;38:715–22
   PubMed Web of Science ®Google Scholar
• Iowa Child Welfare and Substance Abuse Services Collaboration. Available from www.dhs.state.ia.us/cppc/docs/SA_CW_ProgramRecommendations.pdf [last accessed 20 Mar 2013]
   Google Scholar
• Goler NC, Armstrong MA, Taillac CJ, Osejo VM. Substance abuse treatment linked with prenatal visits improves perinatal outcomes: a new standard. J Perinatol 2008;28:597–603
   PubMed Web of Science ®Google Scholar
• El-Mohandes A, Herman AA, Nabil El-Khorazaty M, et al. Prenatal care reduces the impact of illicit drug use on perinatal outcomes. J Perinatol 2003;23:354–60
   PubMedGoogle Scholar